351 related articles for article (PubMed ID: 17023566)
1. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness.
Leaf DE; Goldfarb DS
J Appl Physiol (1985); 2007 Apr; 102(4):1313-22. PubMed ID: 17023566
[TBL] [Abstract][Full Text] [Related]
2. Prevention of acute mountain sickness by acetazolamide: as yet an unfinished story.
Swenson ER; Teppema LJ
J Appl Physiol (1985); 2007 Apr; 102(4):1305-7. PubMed ID: 17194729
[No Abstract] [Full Text] [Related]
3. Acetazolamide: a treatment for chronic mountain sickness.
Richalet JP; Rivera M; Bouchet P; Chirinos E; Onnen I; Petitjean O; Bienvenu A; Lasne F; Moutereau S; León-Velarde F
Am J Respir Crit Care Med; 2005 Dec; 172(11):1427-33. PubMed ID: 16126936
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of low-dose acetazolamide for the prophylaxis of acute mountain sickness.
Dumont L; Tramer MR; Lysakowski C; Mardirosoff C; Kayser B
High Alt Med Biol; 2003; 4(3):399; author reply 400. PubMed ID: 14561245
[No Abstract] [Full Text] [Related]
5. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.
Basnyat B; Gertsch JH; Johnson EW; Castro-Marin F; Inoue Y; Yeh C
High Alt Med Biol; 2003; 4(1):45-52. PubMed ID: 12713711
[TBL] [Abstract][Full Text] [Related]
6. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m).
Carlsten C; Swenson ER; Ruoss S
High Alt Med Biol; 2004; 5(1):33-9. PubMed ID: 15072715
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors and high altitude illnesses.
Swenson ER
Subcell Biochem; 2014; 75():361-86. PubMed ID: 24146388
[TBL] [Abstract][Full Text] [Related]
8. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial.
Basnyat B; Gertsch JH; Holck PS; Johnson EW; Luks AM; Donham BP; Fleischman RJ; Gowder DW; Hawksworth JS; Jensen BT; Kleiman RJ; Loveridge AH; Lundeen EB; Newman SL; Noboa JA; Miegs DP; O'Beirne KA; Philpot KB; Schultz MN; Valente MC; Wiebers MR; Swenson ER
High Alt Med Biol; 2006; 7(1):17-27. PubMed ID: 16544963
[TBL] [Abstract][Full Text] [Related]
9. Acetazolamide for the prophylaxis of acute mountain sickness.
Imray C
BMJ; 2012 Oct; 345():e7077. PubMed ID: 23114063
[No Abstract] [Full Text] [Related]
10. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
van Patot MC; Leadbetter G; Keyes LE; Maakestad KM; Olson S; Hackett PH
High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912
[TBL] [Abstract][Full Text] [Related]
11. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness.
Kayser B; Hulsebosch R; Bosch F
High Alt Med Biol; 2008; 9(1):15-23. PubMed ID: 18331216
[TBL] [Abstract][Full Text] [Related]
12. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
[TBL] [Abstract][Full Text] [Related]
13. Changes in subendocardial viability ratio with acute high-altitude exposure and protective role of acetazolamide.
Salvi P; Revera M; Faini A; Giuliano A; Gregorini F; Agostoni P; Becerra CG; Bilo G; Lombardi C; O'Rourke MF; Mancia G; Parati G
Hypertension; 2013 Apr; 61(4):793-9. PubMed ID: 23438935
[TBL] [Abstract][Full Text] [Related]
14. Acetazolamide and high altitude diseases.
Bradwell AR; Wright AD; Winterborn M; Imray C
Int J Sports Med; 1992 Oct; 13 Suppl 1():S63-4. PubMed ID: 1483796
[TBL] [Abstract][Full Text] [Related]
15. Acute Mountain Sickness Symptom Severity at the South Pole: The Influence of Self-Selected Prophylaxis with Acetazolamide.
Harrison MF; Anderson PJ; Johnson JB; Richert M; Miller AD; Johnson BD
PLoS One; 2016; 11(2):e0148206. PubMed ID: 26848757
[TBL] [Abstract][Full Text] [Related]
16. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis.
Low EV; Avery AJ; Gupta V; Schedlbauer A; Grocott MP
BMJ; 2012 Oct; 345():e6779. PubMed ID: 23081689
[TBL] [Abstract][Full Text] [Related]
17. Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness.
Leshem E; Caine Y; Rosenberg E; Maaravi Y; Hermesh H; Schwartz E
J Travel Med; 2012; 19(5):308-10. PubMed ID: 22943271
[TBL] [Abstract][Full Text] [Related]
18. Acetazolamide improves cerebral oxygenation during exercise at high altitude.
Vuyk J; Van Den Bos J; Terhell K; De Bos R; Vletter A; Valk P; Van Beuzekom M; Van Kleef J; Dahan A
High Alt Med Biol; 2006; 7(4):290-301. PubMed ID: 17173514
[TBL] [Abstract][Full Text] [Related]
19. Normoxic induction of cerebral HIF-1alpha by acetazolamide in rats: role of acidosis.
Xu J; Peng Z; Li R; Dou T; Xu W; Gu G; Liu Y; Kang Z; Tao H; Zhang JH; Ostrowski RP; Lu J; Sun X
Neurosci Lett; 2009 Feb; 451(3):274-8. PubMed ID: 19150486
[TBL] [Abstract][Full Text] [Related]
20. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness.
Lipman GS; Jurkiewicz C; Winstead-Derlega C; Navlyt A; Burns P; Walker A; Phillips C; Reilly A; Burnier A; Romero J; Warner K; Hackett P
High Alt Med Biol; 2019 Sep; 20(3):271-278. PubMed ID: 31259608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
